We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Groups and Patient Advocates Question FDA's ICD Study
Industry Groups and Patient Advocates Question FDA's ICD Study
September 23, 2005
Due to concerns over its methodology and timeliness, both industry officials and patient advocates are questioning how much influence a recent study of implantable cardioverter defibrillators (ICDs) should have in setting FDA policy.